Kaleido Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
14.80
|
|
Average Rating
|
3.50
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
1
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-06-30
|
-0.25
|
0.00
|
0.25
|
100.00%
|
|
2022-03-31
|
-0.58
|
-0.47
|
0.11
|
18.97%
|
|
2021-12-31
|
-0.59
|
-0.48
|
0.11
|
18.64%
|
|
2021-09-30
|
-0.54
|
-0.54
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.57
|
-0.56
|
0.01
|
1.75%
|
|
2021-03-31
|
-0.59
|
-0.58
|
0.01
|
1.69%
|
|
2020-12-31
|
-0.40
|
-0.56
|
-0.16
|
-40.00%
|
|
2020-09-30
|
-0.63
|
-0.65
|
-0.02
|
-3.17%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.47
|
|
2021-12-31
|
-2.16
|
|
2020-12-31
|
-2.44
|
|
2019-12-31
|
-3.74
|
|
2018-12-31
|
-1.02
|